About Insception
Insception is a Healthcare company based in Mississauga (Canada) founded in 1996, and was acquired by Generate in June 2021. It operates as a largest cord blood program in Canada. Its website insception.com draws about 25 thousand monthly visits. Its focus areas include Life Sciences, Life Sciences Platforms and Tools, Research Services and Biorepository. Its competitors include GenVault Corporation, iSpecimen, Indivumed, ViaCell and BioStorage Technologies and 4 more; 7 of its 9 listed competitors have raised funding.
Company details
Insception was founded in 1996 and is based in Mississauga, Canada, within the healthcare sector focused on cord blood banking. Over 39,000 units have been collected, processed, and stored through partnerships with facilities like Mount Sinai Hospital and Scarborough Hospital. Ownership is held by Argosy Partners, Mount Sinai Hospital, management, and scientific founders. Services include secure processing, long-term storage, and governance for Canadian families.
- Latest Funding Round$4.5M (USD), Debt – Venture
Sep 2012
- InvestorsWellington Financial
& 3 more
- Acquired by
Apps and channels of Insception
its YouTube channel Insception Lifebank has 156 subscribers and 30 videos.
Videos from Insception
The most watched videos on Insception's YouTube channel, Insception Lifebank (156 subscribers). Click a video to play it here.
More on Insception Lifebank.
Funding Insights of Insception
- Total Rounds 2
- Last Round Debt – Venture — $4.5M
- First Round $2.75M
(Oct 2006)
- Investors Count 2
All 2 funding rounds of Insception with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Sep 2012 | $4.5M | Debt – Venture | – | – | |
| Oct 2006 | $2.75M | Debt – Venture | – | – |
4 investors in total: 4 institutional.
Investors in Insception
Insception has secured backing from 4 investors, including venture fund and institutional investors. Prominent investors backing the company include Wellington Financial, Generate and MMV Financial.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Tech-focused Venture debt provider investing primarily in the US and Canada | 2000 | wellingtonfund.com | Toronto, Canada | |
Tech & Life-Sciences focused Growth stage Venture Debt Firm investing in North America | – | mmvf.com | Toronto, Canada | |
Private equity fund that buys shares and helps grow owner-managed businesses. | 1999 | successionfund.com | Toronto, Canada | |
Provider of services for the storage of stem cells | 1977 | generate.com | Los Angeles, United States |
Investor details for Insception
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Insception
5 dated milestones of Insception across 25 years, from founding to its latest funding, stage changes and deals.
- Founded Insception is founded.
- Funding First funding round of $2.8M.
- Exit Acquired by The Succession Fund.
- Funding Latest funding round, Debt – Venture, of $4.5M.
- Exit Acquired by Generate.
Competitors of Insception
Insception has 9 listed competitors in our database, 7 of them funded. They include GenVault Corporation, iSpecimen, Indivumed, ViaCell and BioStorage Technologies, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| genvault.com | 2000 | Carlsbad, United States | $47.8M | – | Biosamples are stabilized, transported, stored, and retrieved by GenVault. | |
| ispecimen.com | 2009 | Lexington, United States | $11.86M | 75 | Provider of a biorepository of human clinical specimens | |
| indivumed.com | 2002 | Hamburg, Germany | – | 178 | Biospecimens are collected, preserved, and analyzed for oncology services. | |
| viacellinc.com | 1994 | Cambridge, United States | $63M | – | Provider of services for collecting and preserving umbilical cord blood stem cells | |
| biostorage.com | 2002 | Indianapolis, United States | $8.77M | – | Provides bio repository services | |
| aminochain.io | 2022 | New York, United States | $7.07M | – | A blockchain-based platform for tokenizing and incentivizing stem cell donations | |
| precisionmed.com | 1996 | San Diego, United States | – | – | Human biological materials for research are supplied via a biorepository. | |
| cryoniss.com | 2018 | Macclesfield, United Kingdom | $683,055 | 9 | Provider of biobanking services for life sciences industries | |
| biotransplant.org | 1990 | Boston, United States | $9.7M | – | Supplies tested tissues, allografts, and implantable tissue products for medical use. |
Detailed competitors of Insception
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Insception
The website of Insception (insception.com) receives about 25K visits a month.
- Monthly visits25K
▲ 38.3% vs previous month
Websites whose visitors overlap most with Insception. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| miraclecord.com | 100% | 69.8K | #575,258 | View details | |
esh.org | esh.org | 76% | – | #2,337,047 | – |
chaimcentre.com | chaimcentre.com | 72% | – | – | – |
savethecordfoundation.org | savethecordfoundation.org | 62% | – | #9,035,634 | – |
nationalcordbloodprogram.org | nationalcordbloodprogram.org | 62% | – | – | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 7 similar websites and full traffic analytics for Insception
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 7 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Life Sciences Platforms & Tools
10 companies that operate in the same segment as Insception (Life Sciences Platforms & Tools), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Medidata is recognized as a leading provider of SaaS solutions for clinical research. | 1999 | New York, New York, United States | USD 41.5 M | – | – | |
AI-based solutions for health management are provided. | 2015 | Dallas, Texas, United States | USD 2.8 B | – | 1,111 | |
Nanopore-based electronic systems for single-molecule analysis are developed. | 2005 | Oxford, Oxfordshire, United Kingdom | USD 1.34 B | USD 301.49 M | 1,372 | |
Real-world health data is provided for research and decisions. | 2012 | Menlo Park, California, United States | USD 259.16 M | – | – | |
Genetically modified cell lines are developed using AAV gene-editing platform. | 2007 | Cambridge, Cambridgeshire, United Kingdom | USD 46.29 M | – | – | |
Biological reagents and antibodies are developed for life science research. | 1998 | Cambridge, Cambridgeshire, United Kingdom | USD 78.8 M | – | – | |
Electron microscopy services and microanalysis instruments are provided. | 1956 | Waltham, Massachusetts, United States | – | USD 44.56 B | 125,000 | |
Novel therapeutics are discovered using an AI-enabled drug platform. | 2013 | New York, New York, United States | USD 456.66 M | USD 74.68 M | – | |
A platform for sharing and accessing academic research papers is provided. | 2008 | San Francisco, California, United States | USD 58.4 M | – | – | |
Developer of molecular diagnostic testing solutions | 1996 | Sunnyvale, California, United States | USD 19.1 M | USD 54.88 M | 208 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Insception
Complete news archive for Insception
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Insception
Insception was founded in 1996 and raised its 1st funding round 10 years after it was founded.
Insception is headquartered in Mississauga, Canada. It is registered at Mississauga, Ontario, Canada.
Insception was founded in 1996 and is based in Mississauga, Canada, within the healthcare sector focused on cord blood banking. Over 39,000 units have been collected, processed, and stored through partnerships with facilities like Mount Sinai Hospital and Scarborough Hospital. Ownership is held by Argosy Partners, Mount Sinai Hospital, management, and scientific founders. Services include secure processing, long-term storage, and governance for Canadian families.
Insception's top competitors include iSpecimen, AminoChain and GenVault Corporation.
Insception has 4 investors. Key investors include Wellington Financial, Generate, MMV Financial, and The Succession Fund.
Yes. Insception was acquired by Generate in June 2021.